cardiology careers collections past issues search home
     

J Am Coll Cardiol, 1999; 34:1012-1019
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monin, J.-L.
Right arrow Articles by Gueret, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monin, J.-L.
Right arrow Articles by Gueret, P.

Prediction of functional recovery of viable myocardium after delayed revascularization in postinfarction patients

Accuracy of dobutamine stress echocardiography and influence of long-term vessel patency

Jean-Luc Monin, MD*, J.érôme Garot, MD*, Marielle Scherrer-Crosbie, MD*, Jean Rosso, MD*, Anne-Marie Duval-Moulin, MD*, Patrick Dupouy, MD{dagger}, Emmanuel Teiger, MD{dagger}, Alain Castaigne, MD*, Jean-Claude Cachin, MD*, Jean-Luc Dubois-Rande, MD, PhD* and Pascal Gueret, MD, FACC*

* Fédération de Cardiologie, Hôpital Henri Mondor, 51 Avenue Maréchal De Lattre de Tassigny, 94010, Créteil, France
{dagger} Service des Explorations Fonctionnelles, Hôpital Henri Mondor, AP-HP, 51 Avenue Maréchal De Lattre de Tassigny, 94010, Créteil, France



View larger version (19K):

[in a new window]
 
Figure 1 Three patterns observed at dobutamine echocardiography and relationship between patency of infarct-related vessel at follow-up examination and recovery of LV function. Biphasic = biphasic response; No recov. = no functional recovery; Patent = patent infarct vessel at follow-up; Recov = functional recovery; Reocc = reoccluded infarct vessel at follow-up; Sustained imp. = sustained improvement.

 


View larger version (13K):

[in a new window]
 
Figure 2 Influence of long-term vessel patency on WMSI in viable patients after revascularization. FU = follow-up; Viable all = all patients with myocardial viability at DSE; Viable + patent = patients with viable myocardium at DSE and patent IRA at follow-up; Viab + reocc = patients with viable myocardium at DSE and a reoccluded IRA at follow-up; WMSI: echographic wall motion score index. Data are shown as mean value ± SD. *p = 0.0001. Solid bars = baseline WMSI; open bars = follow-up WMSI.

 


View larger version (15K):

[in a new window]
 
Figure 3 Influence of long-term vessel patency on global LVEF in viable patients after revascularization. LVEF = left ventricular ejection fraction; Viable all = all patients with myocardial viability at DSE; Viable + patent = patients with viable myocardium at DSE and patent IRA at follow-up; Viab + reocc = patients with viable myocardium at DSE and a reoccluded IRA at follow-up. Data are shown as mean value ± SD. *p = 0.02, **p = 0.0004. Solid bars = baseline LVEF; open bars = follow-up LVEF.

 




 
  cardiology careers collections past issues search home